The Use of Advanced Platelet-rich Fibrin in Mandibular Third Molar Surgery
1 other identifier
observational
60
1 country
1
Brief Summary
The purpose of the study is to quantify the levels of platelets and inflammatory markers in A-PRF from a standard venous whole blood sample, and to evaluate the effect of A-PRF on postoperative discomfort and complications following surgical removal of M3. The study will be prospective and include 60 patients referred to Specialtandlægerne Vestergade for surgical removal of one M3. It is expected that the study will contribute with important information on the impact of A-PRF on postoperative sequelae and complications following surgical removal of mandibular third molars.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedAugust 12, 2026
September 1, 2024
3 months
September 18, 2024
August 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Levels of thrombocytes and growth factors in advanced platelet-rich fibrin
Quantification of thrombocytes and specific growth factors (FGF, TGH-B1, VEGF, PDGF-B) released from advanced platelet-rich fibrin measured in concentration levels
From enrollment to one week following surgery
Interventions
Evaluate the level of thrombocytes and growth factors in A-PRF and whole blood sample
Eligibility Criteria
Healthy patients with indication for surgical removal of mandibular third molar
You may qualify if:
- indication for surgical removal of mandibular third molar
You may not qualify if:
- breastfeading, pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Copenhagen
Copenhagen, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2024
First Posted
August 12, 2026
Study Start
October 1, 2024
Primary Completion
December 31, 2024
Study Completion
January 31, 2025
Last Updated
August 12, 2026
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share